Jieming Li
About Jieming Li
Jieming Li is a Principal Scientist at Bristol Myers Squibb with expertise in drug discovery and development, and experience mentoring junior scientists.
Current Role at Bristol Myers Squibb
Jieming Li is currently serving as a Principal Scientist at Bristol Myers Squibb in the Greater New York City Area. In this role, he is involved in advanced research projects within the pharmaceutical industry. As a Principal Scientist, he leads initiatives, collaborates with cross-functional teams, and drives the development of innovative solutions in drug discovery and development.
Previous Experience at Bristol Myers Squibb
Before his current role, Jieming Li worked as a Senior Scientist at Bristol Myers Squibb from 2019 to 2022. During his three-year tenure in the Greater New York City Area, he gained extensive experience in pharmaceutical research, contributing significantly to the company's scientific advancements.
Educational Background in Chemistry
Jieming Li has an impressive educational background in Chemistry. He earned his Doctor of Philosophy (PhD) in Chemistry from the University of Michigan, where he studied from 2013 to 2018. Prior to that, he completed his Bachelor of Science (BS) in Chemistry at Xiamen University, studying from 2009 to 2013. His academic training has provided a strong foundation for his career in the pharmaceutical industry.
Expertise in Drug Discovery and Development
With over four years of experience in the pharmaceutical industry, Jieming Li has developed a deep expertise in drug discovery and development. His work involves significant contributions to advancing scientific projects, collaborating with cross-functional teams, and mentoring junior scientists and researchers to foster innovation and progress in the field.
Contributions to Research Publications
Jieming Li has contributed to multiple research publications in the field of chemistry. His scientific insights and research outputs reflect his dedication and expertise, making impactful contributions to the broader scientific community and advancing knowledge in his field.